Biochemist with previous image duplication retractions loses another paper 

A researcher who retracted two papers last year following a years-long investigation has lost another, this one two decades old. The same journal also corrected two papers for image duplication within days of the retraction. The moves followed comments about image similarities on PubPeer. The retraction marks the third for biochemist Dario Alessi, a professor … Continue reading Biochemist with previous image duplication retractions loses another paper 

Former Italian university head faces retractions and criminal investigations

A prominent Italian pharmacologist under investigation for embezzlement and rigging university contracts has garnered a dozen and a half retractions in the last year for image alterations and duplications. But Salvatore Cuzzocrea, the former rector of the University of Messina, told us he did not agree with the retractions because they were decided “without clear … Continue reading Former Italian university head faces retractions and criminal investigations

Kidney researcher debarred from federal U.S. funding for image manipulation

A former Baylor College of Medicine researcher has been debarred from federal funding for two years after a review by the Office of Research Integrity found evidence of misconduct. Liping Zhang, a former assistant professor in the school’s nephrology section, “engaged in research misconduct in research supported by U.S. Public Health Service (PHS) funds,” according … Continue reading Kidney researcher debarred from federal U.S. funding for image manipulation

Undisclosed conflicts, lightning-fast peer review: One Alzheimer’s journal’s role in a failed drug

Retraction Watch readers are likely familiar with the work of Charles Piller, an award-winning investigative reporter who has been covering problematic research in neuroscience and other fields for Science. We’re pleased to offer an excerpt of his new book, Doctored: Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s, which publishes today. The Journal … Continue reading Undisclosed conflicts, lightning-fast peer review: One Alzheimer’s journal’s role in a failed drug

Journals investigating dozens of papers by leading Canadian urologists

A high-profile Canadian urologist received an editorial expression of concern for one of his papers this month, after anonymous comments on PubPeer flagged suspected data duplication in dozens of his articles.  By our count, sleuths have flagged 30 papers co-authored by Martin Gleave, a professor at the University of British Columbia in Canada and co-founder … Continue reading Journals investigating dozens of papers by leading Canadian urologists

Wiley corrects retraction notices for ‘inaccurate’ description of why articles were pulled

The Journal of Biochemical and Molecular Toxicology, a Wiley title, has corrected a pair of retraction notices in which “the reasons for the retraction were described inaccurately,” according to the corrections. The original notices also did not include “the authors’ disapproval of the retraction.”  The retracted articles, “The cardioprotective effects of a combination of quercetin … Continue reading Wiley corrects retraction notices for ‘inaccurate’ description of why articles were pulled

University of Newcastle investigating top melanoma researchers

The University of Newcastle in Australia is investigating the work of two prominent skin cancer researchers, Retraction Watch has learned.  Commenters on PubPeer have posted questions about the data in 42 papers by Peter Hersey and Xu Dong Zhang, both well-known in Australian melanoma research. So far, two of the papers have been retracted and … Continue reading University of Newcastle investigating top melanoma researchers

Exclusive: One university’s three-year battle to retract papers with fake data

In 2021, the provost of the University of Maryland, Baltimore sounded the alarm about a troubling batch of papers from the lab of Richard Eckert, the former chair of the Department of Biochemistry and Molecular Biology at the institution.  The provost sent letters to the editors of seven journals calling out a string of serious … Continue reading Exclusive: One university’s three-year battle to retract papers with fake data

Nobel prize-winner tallies two more retractions, bringing total to 13

A Nobel prize-winning genetics researcher has retracted two more papers, bringing his total to 13.  Gregg Semenza, a professor of genetic medicine and director of the vascular program at Johns Hopkins’ Institute for Cell Engineering in Baltimore, shared the 2019 Nobel prize in physiology or medicine for “discoveries of how cells sense and adapt to … Continue reading Nobel prize-winner tallies two more retractions, bringing total to 13

First-time scientific sleuths prompt nine retractions for neurosurgery group

Two Dutch researchers were preparing a review of preclinical animal models for hemorrhagic stroke last July when they stumbled across a disturbing pattern in the literature.  First, they found many more papers on the topic than the 50 or so they expected based on their experience: more than 600.  Also, nearly every study proposed a … Continue reading First-time scientific sleuths prompt nine retractions for neurosurgery group